Back to resultsMicrocurrent Therapy and Low-Level Laser Therapy on Wound Healing
Primary Purpose
Wound Healing Delayed
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Microcurrent therapy
Low Level Laser Therapy
Medical therapy
Sponsored by
About this trial
This is an interventional treatment trial for Wound Healing Delayed
Eligibility Criteria
Inclusion Criteria:
- patient recently undergo appendectomy
Exclusion Criteria:
- patient with neurological disorders
- patient with metabolic disorders
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Experimental
Arm Label
medical therapy group
medical therapy and Microcurrent group
medical therapy and Low-Level Laser Therapy group
Arm Description
formed of 20 patients to whom ordinary medical therapy as the pervious groups and placebo shame laser had been applied.
formed of 20 patients to whom the microcurrent therapy had been applied with ordinary medical therapy.
formed of 20 patients to whom the Low Level Laser Therapy had been applied with ordinary medical therapy.
Outcomes
Primary Outcome Measures
levels of matrix metalloproteinases
analyze by Enzyme-linked immunosorbent assay
Secondary Outcome Measures
levels of matrix metalloproteinases
analyze by Enzyme-linked immunosorbent assay
the tissue inhibitors of metalloproteinases
analyze by Enzyme-linked immunosorbent assay
the tissue inhibitors of metalloproteinases
analyze by Enzyme-linked immunosorbent assay
Full Information
NCT ID
NCT05326022
First Posted
March 23, 2022
Last Updated
April 6, 2022
Sponsor
Nehad Ahmed Youness Abo-zaid
1. Study Identification
Unique Protocol Identification Number
NCT05326022
Brief Title
Microcurrent Therapy and Low-Level Laser Therapy on Wound Healing
Official Title
Microcurrent Therapy Versus Low-Level Laser Therapy on Post-surgical Wound Healing
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
April 28, 2022 (Anticipated)
Primary Completion Date
September 30, 2022 (Anticipated)
Study Completion Date
October 30, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Nehad Ahmed Youness Abo-zaid
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The study aiming to compare between the Microcurrent and Low-Level Laser Therapy on wound healing
Detailed Description
The study designed to compare between the Microcurrent and Low-Level Laser Therapy on wound healing
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound Healing Delayed
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
90 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
medical therapy group
Arm Type
Experimental
Arm Description
formed of 20 patients to whom ordinary medical therapy as the pervious groups and placebo shame laser had been applied.
Arm Title
medical therapy and Microcurrent group
Arm Type
Experimental
Arm Description
formed of 20 patients to whom the microcurrent therapy had been applied with ordinary medical therapy.
Arm Title
medical therapy and Low-Level Laser Therapy group
Arm Type
Experimental
Arm Description
formed of 20 patients to whom the Low Level Laser Therapy had been applied with ordinary medical therapy.
Intervention Type
Device
Intervention Name(s)
Microcurrent therapy
Intervention Description
Microcurrent therapy
Intervention Type
Device
Intervention Name(s)
Low Level Laser Therapy
Intervention Description
Laser therapy
Intervention Type
Other
Intervention Name(s)
Medical therapy
Intervention Description
Medical therapy
Primary Outcome Measure Information:
Title
levels of matrix metalloproteinases
Description
analyze by Enzyme-linked immunosorbent assay
Time Frame
assessed at day 3 post operative
Secondary Outcome Measure Information:
Title
levels of matrix metalloproteinases
Description
analyze by Enzyme-linked immunosorbent assay
Time Frame
assessed at day 30 post operative
Title
the tissue inhibitors of metalloproteinases
Description
analyze by Enzyme-linked immunosorbent assay
Time Frame
assessed at day 3 post operative
Title
the tissue inhibitors of metalloproteinases
Description
analyze by Enzyme-linked immunosorbent assay
Time Frame
assessed at day 30 post operative
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
10 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patient recently undergo appendectomy
Exclusion Criteria:
patient with neurological disorders
patient with metabolic disorders
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nehad A. Abo-Zaid, PhD
Phone
+201223265216
Email
dr.nehadahmed@svu.edu.eg
First Name & Middle Initial & Last Name or Official Title & Degree
Mohammed E. Ali, PhD
Phone
+201011212425
Email
m.essam@svu.edu.eg
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nehad A. Abo-Zaid, PhD
Organizational Affiliation
South Valley University
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
27547189
Citation
Dickinson LE, Gerecht S. Engineered Biopolymeric Scaffolds for Chronic Wound Healing. Front Physiol. 2016 Aug 5;7:341. doi: 10.3389/fphys.2016.00341. eCollection 2016.
Results Reference
background
Learn more about this trial
Microcurrent Therapy and Low-Level Laser Therapy on Wound Healing
We'll reach out to this number within 24 hrs